Home Amines 857267-04-0
857267-04-0,MFCD06805167
Catalog No.:AA0036BL

857267-04-0 | 1-isopropylpyrazol-3-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$16.00   $11.00
- +
250mg
95%
in stock  
$19.00   $14.00
- +
500mg
95%
in stock  
$35.00   $25.00
- +
1g
95%
in stock  
$43.00   $30.00
- +
5g
95%
in stock  
$202.00   $142.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0036BL
Chemical Name:
1-isopropylpyrazol-3-amine
CAS Number:
857267-04-0
Molecular Formula:
C6H11N3
Molecular Weight:
125.1716
MDL Number:
MFCD06805167
SMILES:
CC(n1ccc(n1)N)C
Properties
Properties
 
Form:
Liquid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
92.3  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
0.6  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROCHEHOLDINGAG;DISHMANPHARMACEUTICALS&CHEMICALSLIMITED-WO2020/79207,2020,A1Locationinpatent:Page/Pagecolumn19-21

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/21032,2008,A1Locationinpatent:Page/Pagecolumn55

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/211463,2019,A1Locationinpatent:Page/Pagecolumn163

[4]Wang,Tao;Banerjee,Daliya;Bohnert,Tonika;Chao,Jianhua;Enyedy,Istvan;Fontenot,Jason;Guertin,Kevin;Jones,Howard;Lin,EdwardY.;Marcotte,Douglas;Talreja,Tina;VanVloten,Kurt[BioorganicandMedicinalChemistryLetters,2015,vol.25,#15,p.2985-2990]

[5]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2019/23147,2019,A1Locationinpatent:Page/Pagecolumn439;440

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2019/23145,2019,A1Locationinpatent:Page/Pagecolumn432;433

[7]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2019/79119,2019,A1Locationinpatent:Page/Pagecolumn447;448

[8]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2020/86728,2020,A1Locationinpatent:Page/Pagecolumn265-266

[9]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/166627,2019,A1Locationinpatent:Page/Pagecolumn103-104

[10]CurrentPatentAssignee:CLAVIUSPHARMACEUTICALS-WO2019/5241,2019,A1Locationinpatent:Paragraph0088

[11]CurrentPatentAssignee:SYNCOMB.V.;ROCHEHOLDINGAG-WO2020/104657,2020,A1Locationinpatent:Page/Pagecolumn69

857267-04-0   
2-(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(1-isopropyl-1H-pyrazol-3-yl)-propionamide 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/21032,2008,A1Locationinpatent:Page/Pagecolumn55-56

isopropylhydrazinehydrochloride 
  920-37-6    857267-04-0    3524-16-1 

[1]CurrentPatentAssignee:ASTRAZENECAPLC;SCHUCKMANNALFREDVON-WO2005/60970,2005,A1Locationinpatent:Page/Pagecolumn161

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2005/121110,2005,A1Locationinpatent:Page/Pagecolumn130-131

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2005/121110,2005,A1Locationinpatent:Page/Pagecolumn130

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:857267-04-0 Molecular Formula|857267-04-0 MDL|857267-04-0 SMILES|857267-04-0 1-isopropylpyrazol-3-amine